Matches in Wikidata for { <http://www.wikidata.org/entity/Q57949352> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q57949352 description "article scientifique publié en 2008" @default.
- Q57949352 description "artículu científicu espublizáu en febreru de 2008" @default.
- Q57949352 description "im Februar 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57949352 description "scientific article published on 27 February 2008" @default.
- Q57949352 description "wetenschappelijk artikel" @default.
- Q57949352 description "наукова стаття, опублікована в лютому 2008" @default.
- Q57949352 name "Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma" @default.
- Q57949352 name "Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma" @default.
- Q57949352 type Item @default.
- Q57949352 label "Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma" @default.
- Q57949352 label "Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma" @default.
- Q57949352 prefLabel "Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma" @default.
- Q57949352 prefLabel "Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma" @default.
- Q57949352 P1433 Q57949352-E277E38D-E373-4317-A807-7B844C55338C @default.
- Q57949352 P1476 Q57949352-D424C2C8-C4A0-4658-A68C-17E1109C31C4 @default.
- Q57949352 P2093 Q57949352-12BA8B38-1A5D-461D-B413-406314EEA643 @default.
- Q57949352 P2093 Q57949352-3BD2BD32-7708-44AE-A60A-B7A3311FA832 @default.
- Q57949352 P2093 Q57949352-4C0944E2-32DC-428E-BA26-0A797B56AF8D @default.
- Q57949352 P2093 Q57949352-5E669493-5C80-4B9C-B09B-A71A3C05A9FB @default.
- Q57949352 P2093 Q57949352-60ACD094-BAB4-43E1-A4EC-3B163B3A9E1E @default.
- Q57949352 P2093 Q57949352-8DC5E7CB-6044-4C50-963B-70D7F67543B8 @default.
- Q57949352 P2093 Q57949352-8DC8DD1B-C0DC-41CB-B97B-3050A72BC272 @default.
- Q57949352 P2093 Q57949352-A7150A05-9339-4A94-AD8B-00A9F4A58E5A @default.
- Q57949352 P2093 Q57949352-A9D984B5-A98D-45AE-A6B0-7E8BEB8E4F9D @default.
- Q57949352 P2093 Q57949352-AE07D8AA-FC67-42FF-B696-F3643D61C0DF @default.
- Q57949352 P2093 Q57949352-B30E40C7-5C1C-4A86-AE06-69D0DC95696E @default.
- Q57949352 P2093 Q57949352-C38A29DA-47AA-441F-A0A1-386A911F5C95 @default.
- Q57949352 P2860 Q57949352-3B2706BF-60A5-4936-88A4-25B3BB77FA27 @default.
- Q57949352 P2860 Q57949352-6FE24FCD-E78B-42D0-AC2E-A57F4F6B70BB @default.
- Q57949352 P2860 Q57949352-D1F0C4CC-E50E-4AB3-A379-378716EA2AA8 @default.
- Q57949352 P2888 Q57949352-86446E54-DCFA-4442-BB9E-0959A2C93FE9 @default.
- Q57949352 P304 Q57949352-A362CEF9-C030-4AFC-BCDF-AC6993F47AF3 @default.
- Q57949352 P31 Q57949352-D15D7D34-40B1-477B-A770-A1C8F9D6C176 @default.
- Q57949352 P356 Q57949352-3925F5BE-8F99-4742-A96D-AD8E007C9D0E @default.
- Q57949352 P433 Q57949352-A05AB353-CEE2-4C4C-AC98-5FF707D45C24 @default.
- Q57949352 P478 Q57949352-1636677E-145A-4A0A-9E65-7901B0B90675 @default.
- Q57949352 P50 Q57949352-CA583305-8AFE-4586-BDAD-344B0D8A8048 @default.
- Q57949352 P577 Q57949352-C9D7F004-2CE7-4D9B-8764-33CF6927AD34 @default.
- Q57949352 P698 Q57949352-88BA2D87-6E5E-4B8F-913A-9DBB1E3CD4E8 @default.
- Q57949352 P921 Q57949352-3BB5B56E-2294-49CD-8C93-2904DE0BECC4 @default.
- Q57949352 P921 Q57949352-3C1EB02E-FDC9-4FE0-A8AA-8FCC713598DD @default.
- Q57949352 P921 Q57949352-76845C99-BBF4-43CC-9294-3CA65720EB5E @default.
- Q57949352 P356 S00262-008-0491-8 @default.
- Q57949352 P698 18301889 @default.
- Q57949352 P1433 Q5031409 @default.
- Q57949352 P1476 "Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma" @default.
- Q57949352 P2093 "Céline Galéa" @default.
- Q57949352 P2093 "Emmanuelle Bompas" @default.
- Q57949352 P2093 "Eve Marie Neidhardt" @default.
- Q57949352 P2093 "Irène Philip" @default.
- Q57949352 P2093 "Jaafar Bennouna" @default.
- Q57949352 P2093 "Jérôme Tiollier" @default.
- Q57949352 P2093 "Marie Audrain" @default.
- Q57949352 P2093 "Marie Rimbert" @default.
- Q57949352 P2093 "Samuel Salot" @default.
- Q57949352 P2093 "Soraya Saiagh" @default.
- Q57949352 P2093 "Sylvie Lafaye-de Micheaux" @default.
- Q57949352 P2093 "Sylvie Négrier" @default.
- Q57949352 P2860 Q40468302 @default.
- Q57949352 P2860 Q43775068 @default.
- Q57949352 P2860 Q46740248 @default.
- Q57949352 P2888 s00262-008-0491-8 @default.
- Q57949352 P304 "1599-1609" @default.
- Q57949352 P31 Q13442814 @default.
- Q57949352 P356 "10.1007/S00262-008-0491-8" @default.
- Q57949352 P433 "11" @default.
- Q57949352 P478 "57" @default.
- Q57949352 P50 Q42870916 @default.
- Q57949352 P577 "2008-02-27T00:00:00Z" @default.
- Q57949352 P698 "18301889" @default.
- Q57949352 P921 Q1164529 @default.
- Q57949352 P921 Q181600 @default.
- Q57949352 P921 Q19000948 @default.